Alexandra Stubelius

The overall goal of Alexandra Stubelius’ research is to reshape and remodel the immunesystem to reduce inflammation and restore tissue function. This is achieved through advanced nanotherapeutics and specifcally designed biomaterials. She holds a PhD in Medicine, specialized in inflammation and rheumatology, a MSc in Pharmacy and Pharmaceutical Biosciences and did a postdoc in nanomedicine at the University of California, San Diego.

At Chalmers, she sits in the steering committee of the Area of Advance Nano, and is also active in the Area of Advance Health Engineering as well as Area of Advance Materials Science.

For her interests in developing novel therapeutic approaches, she is sits on the board of the Controlled Release Society Nordic Local Chapter, and she is highly involved in the Nordic University Consortium NordicPOP (patient oriented products) and its continuation NordicPharmaTrain, both focusing on Nordic academic and industrial Collaborations to strengthen Nordic Drug Delivery Research.

For her interest in joint diseases, she is involved in the EU-funded network NetwOArk, with a mission to set up a European Society for Osteoarthritis.

Since 2024, she is also the Director of the Master Program in Biotechnology at Chalmers, and teaches pharmaceutical technologies for pharmacy students at the University of Gothenburg.